A Comparison of Short- and Long-Term Therapeutic Outcomes of Infliximab- versus Tacrolimus-Based Strategies for Steroid-Refractory Ulcerative Colitis

Background/Aims. Antitumor necrosis factor antibodies and calcineurin inhibitors have shown good therapeutic efficacy for steroid-refractory ulcerative colitis (UC). Although some studies have compared the efficacy of infliximab (IFX) and cyclosporin A, there are no published studies comparing IFX a...

Descripción completa

Detalles Bibliográficos
Autores principales: Endo, Katsuya, Onodera, Motoyuki, Shiga, Hisashi, Kuroha, Masatake, Kimura, Tomoya, Hiramoto, Keiichiro, Kakuta, Yoichi, Kinouchi, Yoshitaka, Shimosegawa, Tooru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745932/
https://www.ncbi.nlm.nih.gov/pubmed/26904108
http://dx.doi.org/10.1155/2016/3162595

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4745932/
https://www.ncbi.nlm.nih.gov/pubmed/26904108
http://dx.doi.org/10.1155/2016/3162595

Ejemplares similares